Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
3 MedTech Stocks Likely to Beat Estimates This Earnings Season
09:02am, Wednesday, 08'th Feb 2023
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EXAS, MDT and IART are poised ahead of their earnings releases.
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
05:21pm, Tuesday, 07'th Feb 2023 Zacks Investment Research
Continued increase in Cologuard volume is likely to have benefited Exact Sciences (EXAS) Q4 performance.
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
01:33pm, Tuesday, 07'th Feb 2023
Continued increase in Cologuard volume is likely to have benefited Exact Sciences (EXAS) Q4 performance.
Is Biotech Immunocore About To Make A 25% Price Move?
07:00am, Tuesday, 07'th Feb 2023
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Inc
Exact Sciences (EXAS) Stock Moves -0.46%: What You Should Know
11:15pm, Monday, 06'th Feb 2023 Zacks Investment Research
Exact Sciences (EXAS) closed the most recent trading day at $67.14, moving -0.46% from the previous trading session.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
01:50pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Could Exact Sciences Stock Help You Become a Millionaire?
01:45pm, Friday, 03'rd Feb 2023 The Motley Fool
The stock is full of potential -- and risk.
Could Exact Sciences Stock Help You Become a Millionaire?
08:45am, Friday, 03'rd Feb 2023
Exact Sciences' revenue has doubled in just a few years, and sales of its Cologuard test continue to soar.
1 Soaring Growth Stock to Buy and Hold for 10 Years
03:15pm, Thursday, 02'nd Feb 2023 The Motley Fool
Moving forward, this company could perform much better than it did last year.
1 Soaring Growth Stock to Buy and Hold for 10 Years
10:15am, Thursday, 02'nd Feb 2023
Moving forward, this company could perform much better than it did last year.
Cathie Wood Is Doubling Down on This Hidden-Gem Artificial Intelligence Stock
10:04am, Thursday, 02'nd Feb 2023
In November 2021, Cathie Wood described artificial intelligence as the “next big frontier” of the tech sector. Roughly a year later, OpenAI released advanced chatbot ChatGPT, and almost overnight,
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
02:09am, Wednesday, 01'st Feb 2023 Benzinga
Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: HOOD) at an estimated valuation of over $888,000, based on Tuesday’s cl
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
01:50pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
11:00pm, Monday, 30'th Jan 2023 Zacks Investment Research
Exact Sciences (EXAS) closed the most recent trading day at $66.21, moving -1.88% from the previous trading session.
Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year?
02:40pm, Monday, 30'th Jan 2023 Zacks Investment Research
Here is how Exact Sciences (EXAS) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
